2011 CVM News: Finding may permit drug delivery to the brain - for Alzheimer's, multiple sclerosis and brain cancers

dc.contributor.author	Office of Communications
dc.date.accessioned	2018-08-24T12:56:28Z
dc.date.available	2018-08-24T12:56:28Z
dc.date.issued	2011-09-14
dc.description.abstract	This news item from the Cornell Chronicle is about: Cornell researchers may have solved a 100-year puzzle: How to safely open and close the blood-brain barrier so that therapies to treat Alzheimer's disease, multiple sclerosis and cancers of the central nervous system might effectively be delivered. The researchers have identified that adenosine, a molecule produced by the body with many physiological functions including signaling trauma, can modulate the entry of large molecules into the brain. For the first time, the researchers discovered that when adenosine receptors are activated on cells that comprise the blood-brain barrier, a gateway into the blood-brain barrier can be established.
dc.identifier.uri	https://hdl.handle.net/1813/58534
dc.language.iso	en_US
dc.publisher	Cornell University, College of Veterinary Medicine
dc.subject	Cornell University. College of Veterinary Medicine -- Periodicals.; Bynoe, Margaret; Cornell Chronicle; Ramanujan, Krishna
dc.title	2011 CVM News: Finding may permit drug delivery to the brain - for Alzheimer's, multiple sclerosis and brain cancers
dc.title.alternative	2011 CVM News: Breaching the blood-brain barrier
dc.type	article

Files

Now showing 1 - 1 of 1